ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 234 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q2 2017. The put-call ratio across all filers is 0.23 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $605,000 | -60.9% | 49,000 | -53.9% | 0.05% | -62.2% |
Q4 2017 | $1,548,000 | -54.8% | 106,400 | -55.8% | 0.14% | -8.2% |
Q3 2017 | $3,426,000 | +167.7% | 240,800 | +140.1% | 0.15% | +30.1% |
Q2 2017 | $1,280,000 | +0.6% | 100,300 | 0.0% | 0.11% | -8.9% |
Q1 2017 | $1,272,000 | +18.3% | 100,300 | -4.7% | 0.12% | -1.6% |
Q4 2016 | $1,075,000 | -25.9% | 105,300 | -4.4% | 0.13% | -33.3% |
Q3 2016 | $1,451,000 | -1.5% | 110,200 | -5.0% | 0.19% | -12.1% |
Q2 2016 | $1,473,000 | -47.3% | 116,000 | -45.2% | 0.22% | -51.2% |
Q1 2016 | $2,796,000 | -15.7% | 211,680 | -1.9% | 0.44% | -19.7% |
Q4 2015 | $3,317,000 | +6.7% | 215,680 | -14.0% | 0.55% | +6.0% |
Q3 2015 | $3,108,000 | -9.4% | 250,680 | 0.0% | 0.52% | -3.0% |
Q2 2015 | $3,429,000 | +14.4% | 250,680 | 0.0% | 0.53% | +13.9% |
Q1 2015 | $2,998,000 | +11.4% | 250,680 | +19.0% | 0.47% | +2.6% |
Q4 2014 | $2,690,000 | +228.0% | 210,680 | +244.8% | 0.46% | +165.7% |
Q3 2014 | $820,000 | – | 61,110 | – | 0.17% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tamarack Advisers, LP | 1,375,000 | $20,006,000 | 10.92% |
Adirondack Research & Management Inc. | 574,033 | $8,352,000 | 3.28% |
GLENHILL ADVISORS LLC | 2,461,034 | $35,808,000 | 2.64% |
PARADIGM CAPITAL MANAGEMENT INC/NY | 1,949,600 | $28,367,000 | 2.42% |
DALTON GREINER HARTMAN MAHER & CO | 2,990,902 | $43,518,000 | 2.28% |
S&T BANK/PA | 703,223 | $10,231,000 | 1.73% |
Tibra Equities Europe Ltd | 263,344 | $3,832,000 | 1.64% |
Millrace Asset Group, Inc. | 116,675 | $1,697,000 | 1.63% |
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 1,271,450 | $18,502,000 | 1.31% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 9,423,223 | $137,108,000 | 1.15% |